-
Mallinckrodt receives FDA approval for Xartemis XR
DUBLIN — Mallinckrodt Plc last week announced that the Food and Drug Administration approved Xartemis XR (oxycodone hydrochloride and acetaminophen) Extended-Release Tablets (CII), for the management of acute pain severe enough that it requires opioid treatment.
The drug also is indicated for patients for whom alternative treatments have shown to be ineffective. Xartemis XR, previously known as MNK-795, is the first and only extended-release oral combination of two clinically proven pain medications — oxycodone and acetaminophen.
-
Coffee Bean & Tea Leaf announces K-cup flavors
LOS ANGELES — The Coffee Bean & Tea Leaf, a coffee and tea retailer, announced the introduction of four coffee varieties for the Keurig K-Cup Brewing System. The new offerings highlight some of the company's most popular selections, as well as new blends that were created specifically for the Keurig system.